Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
EKSO - Ekso Bionics Holdings Inc - Stock Price Chart
TickerEKSO [NASD]
CompanyEkso Bionics Holdings Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap23.63MEPS (ttm)-1.10
P/E-EPS this Y55.45%
Forward P/E-EPS next Y51.02%
PEG-EPS past 5Y30.19%
P/S1.29EPS next 5Y-
P/B1.55EPS Q/Q7.87%
Dividend-Sales Q/Q36.50%
Insider Own16.63%Inst Own7.89%
Insider Trans0.46%Inst Trans2.43%
Short Float0.90%EarningsMar 04/a
Analyst Recom1.00Target Price9.25
Avg Volume170.37K52W Range0.62 - 3.13
Apr-12-24 08:00AM Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal (GlobeNewswire) +8.53%
Mar-05-24 09:18AM Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript (Insider Monkey) -24.76%
Mar-04-24 07:51PM EKSO Stock Earnings: Ekso Bionics Holdings Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +5.53%
05:20PM Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:19PM Ekso Bionics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM Ekso Bionics Reports Record Annual Revenue of $18.3 Million (GlobeNewswire)
Feb-26-24 08:00AM Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024 (GlobeNewswire)
Jan-11-24 08:00AM Ekso Bionics Announces $4.6 Million Registered Direct Offering (GlobeNewswire) -7.19%
Jan-08-24 04:05PM Ekso Bionics Launches GaitCoach Software for EksoNR (GlobeNewswire)
Jan-04-24 05:05PM Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
GVH - Globavend Holdings Limited - Stock Price Chart
TickerGVH [NASD]
CompanyGlobavend Holdings Limited
CountryAustralia
IndustryIntegrated Freight & Logistics
Market Cap15.65MEPS (ttm)0.07
P/E14.46EPS this Y33.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.84EPS next 5Y-
P/B-EPS Q/Q48.40%
Dividend-Sales Q/Q-10.10%
Insider Own78.25%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float2.26%Earnings-
Analyst Recom-Target Price-
Avg Volume78.23K52W Range0.79 - 5.50
Mar-18-24 03:42AM Globavend Holdings Limited Enters Into a US$20,000,000 Equity Line of Credit Facility to be Registered on Form F-1 (GlobeNewswire)
Nov-10-23 01:47PM Globavend Holdings Limited Announces Closing of its Initial Public Offering (GlobeNewswire)
Nov-07-23 04:05PM Globavend Holdings Limited Announces Pricing of Initial Public Offering (GlobeNewswire)
CYTH - Cyclo Therapeutics Inc - Stock Price Chart
TickerCYTH [NASD]
CompanyCyclo Therapeutics Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap33.32MEPS (ttm)-1.31
P/E-EPS this Y53.66%
Forward P/E-EPS next Y15.79%
PEG-EPS past 5Y-88.22%
P/S30.85EPS next 5Y-
P/B6.96EPS Q/Q61.44%
Dividend-Sales Q/Q66.70%
Insider Own44.40%Inst Own7.71%
Insider Trans0.00%Inst Trans0.36%
Short Float0.29%EarningsMar 18/b
Analyst Recom1.00Target Price4.00
Avg Volume108.09K52W Range0.68 - 2.57
Mar-19-24 06:53AM CYTH Stock Earnings: Cyclo Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Mar-18-24 09:05AM Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (Business Wire)
Mar-14-24 09:34AM Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol Cyclo for the Treatment of Alzheimers Disease (Business Wire)
Mar-13-24 05:04PM Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Jan-29-24 09:15AM Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimers Disease from the U.S. Patent and Trademark Office (Business Wire)
Dec-27-23 04:15PM Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. (Business Wire) -7.87%
Dec-18-23 09:15AM Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol Cyclo Clinical Program for the Treatment of Niemann-Pick Disease Type C1 (Business Wire)
Dec-14-23 04:01PM Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Nov-21-23 08:05AM Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium 2024 (Business Wire) -8.82%
Nov-15-23 08:05AM Cyclo Therapeutics Reports Third Quarter 2023 Financial Results (Business Wire)
NXPL - NextPlat Corp - Stock Price Chart
TickerNXPL [NASD]
CompanyNextPlat Corp
CountryUSA
IndustrySoftware - Application
Market Cap22.46MEPS (ttm)-0.23
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y70.44%
P/S0.59EPS next 5Y-
P/B0.70EPS Q/Q-32.22%
Dividend-Sales Q/Q532.39%
Insider Own65.76%Inst Own1.29%
Insider Trans0.00%Inst Trans3.00%
Short Float0.60%Earnings-
Analyst Recom-Target Price-
Avg Volume799.27K52W Range1.21 - 4.26
Apr-12-24 10:16AM Why Is NextPlat (NXPL) Stock Up 34% Today? (InvestorPlace) +24.67%
09:52AM NXPL Stock Earnings: NextPlat Reported Results for Q4 2023 (InvestorPlace)
08:41AM NextPlat Announces Proposed Business Combination with Progressive Care Inc. (PR Newswire)
Apr-11-24 04:38PM NextPlat Reports Consolidated Year-End 2023 Results with Increased Revenues of $37.8 Million, Record Annual Margins of 30% and $26.3 Million in Cash (PR Newswire) +7.53%
04:00PM Progressive Care Inc. Announces Record Full Year 2023 Results with Revenues of $49.7 Million, an Increase of 22% with Annual Gross Margins of 30% (PR Newswire)
Mar-26-24 08:50AM NextPlat Expands North American Technology E-Commerce Business with Acquisition of Outfitter Satellite Inc. (PR Newswire)
Feb-28-24 09:31AM NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st (PR Newswire)
Feb-05-24 08:09AM NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China (PR Newswire) +6.08%
Dec-14-23 08:00AM Progressive Care's PharmcoRx Pharmacies Expands Medicare Advantage Over-the-Counter Benefits Acceptance Program Through New Agreement with ProHealth Connect (PR Newswire) +9.74%
Nov-27-23 08:00AM PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings (PR Newswire)
HKIT - Hitek Global Inc - Stock Price Chart
TickerHKIT [NASD]
CompanyHitek Global Inc
CountryChina
IndustrySoftware - Application
Market Cap15.41MEPS (ttm)0.07
P/E14.71EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-11.12%
P/S3.38EPS next 5Y-
P/B0.54EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own59.91%Inst Own1.19%
Insider Trans0.00%Inst Trans-
Short Float0.81%EarningsApr 09/a
Analyst Recom-Target Price-
Avg Volume2.16M52W Range0.54 - 39.80
Apr-09-24 08:30AM Hitek Global Inc. Announces Fiscal Year 2023 Financial Results (PR Newswire) -8.00%
Feb-08-24 12:19PM 5 Investors Betting Big on Hitek Global (HKIT) Stock (InvestorPlace) +218.42%
07:59AM Why Is Hitek Global (HKIT) Stock Up 518% Today? (InvestorPlace)
Nov-07-23 08:00AM Hitek Global Inc. Announces First Half of Fiscal Year 2023 Financial Results (PR Newswire) -6.30%
Jul-28-23 10:10AM Calculating The Fair Value Of Hitek Global Inc. (NASDAQ:HKIT) (Simply Wall St.) +16.78%
Jul-01-23 09:02AM Hitek Global Inc. (NASDAQ:HKIT) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? (Simply Wall St.)
08:16AM Some Hitek Global Inc. (NASDAQ:HKIT) Shareholders Look For Exit As Shares Take 55% Pounding (Simply Wall St.)
Jun-14-23 08:00AM Hitek Global Inc. Receives Government Reward for Successful Listing on Nasdaq (GlobeNewswire)
Apr-27-23 09:30PM Hitek Global Inc. Announces Fiscal Year 2022 Financial Results (PR Newswire)
Apr-04-23 12:00PM Hitek Global Inc. Announces Closing of Initial Public Offering (GlobeNewswire) -11.97%
COCH - Envoy Medical Inc - Stock Price Chart
TickerCOCH [NASD]
CompanyEnvoy Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap99.18MEPS (ttm)-0.18
P/E-EPS this Y60.50%
Forward P/E-EPS next Y-2.13%
PEG-EPS past 5Y-
P/S583.39EPS next 5Y-
P/B-EPS Q/Q-558.73%
Dividend-Sales Q/Q-
Insider Own68.65%Inst Own9.31%
Insider Trans0.09%Inst Trans-
Short Float0.69%EarningsApr 02/b
Analyst Recom1.00Target Price5.50
Avg Volume438.78K52W Range0.75 - 11.72
Apr-03-24 08:05AM Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024 (GlobeNewswire) +22.32%
Apr-02-24 10:53PM COCH Stock Earnings: Envoy Medical Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:00AM Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-12-24 10:52AM Envoy Medical to Participate in the 36th Annual ROTH Conference (GlobeNewswire)
Mar-04-24 09:20AM Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial (GlobeNewswire) +39.20%
Feb-07-24 09:00AM Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices as Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage (GlobeNewswire) -16.67%
Feb-05-24 11:00AM Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley (GlobeNewswire) +26.75%
Jan-30-24 08:05AM Envoy Medical, Inc. to Present at The Microcap Conference (Newsfile)
Jan-22-24 09:30AM MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger (NASDAQ: COCH) (PR Newswire)
09:00AM Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems (GlobeNewswire)
INTJ - Intelligent Group Ltd - Stock Price Chart
TickerINTJ [NASD]
CompanyIntelligent Group Ltd
CountryHong Kong
IndustryConsulting Services
Market Cap20.80MEPS (ttm)0.04
P/E39.65EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S7.94EPS next 5Y-
P/B9.39EPS Q/Q-48.09%
Dividend-Sales Q/Q56.98%
Insider Own68.61%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float1.77%Earnings-
Analyst Recom-Target Price-
Avg Volume732.37K52W Range1.51 - 7.87
Mar-19-24 08:47PM Intelligent Group Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq (GlobeNewswire)
NURO - Neurometrix Inc. - Stock Price Chart
TickerNURO [NASD]
CompanyNeurometrix Inc.
CountryUSA
IndustryMedical Devices
Market Cap8.62MEPS (ttm)-5.94
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.46EPS next 5Y15.00%
P/B0.33EPS Q/Q-50.24%
Dividend-Sales Q/Q-28.67%
Insider Own16.01%Inst Own5.68%
Insider Trans0.00%Inst Trans3.51%
Short Float0.68%EarningsFeb 22/b
Analyst Recom1.00Target Price50.00
Avg Volume44.64K52W Range2.70 - 11.82
Today 08:00AM NeuroMetrix Announces Steps Taken to Enhance Shareholder Value (GlobeNewswire) +18.63%
Mar-14-24 09:00AM NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy (GlobeNewswire)
Mar-13-24 09:00AM NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell Fibromyalgia (GlobeNewswire)
Mar-12-24 08:00AM Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired (ACCESSWIRE)
Mar-08-24 11:15AM RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc. (ACCESSWIRE)
Mar-04-24 08:00AM Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc. (ACCESSWIRE) -5.97%
Feb-23-24 11:23AM NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcript (Insider Monkey) +5.78%
Feb-22-24 10:28PM Q4 2023 NeuroMetrix Inc Earnings Call (Thomson Reuters StreetEvents) -7.26%
07:00AM NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights (GlobeNewswire)
Feb-15-24 09:00AM NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call (GlobeNewswire) +9.57%
EPIX - Essa Pharma Inc - Stock Price Chart
TickerEPIX [NASD]
CompanyEssa Pharma Inc
CountryCanada
IndustryBiotechnology
Market Cap279.60MEPS (ttm)-0.59
P/E-EPS this Y-31.33%
Forward P/E-EPS next Y-32.74%
PEG-EPS past 5Y25.04%
P/S-EPS next 5Y-
P/B1.98EPS Q/Q11.63%
Dividend-Sales Q/Q-
Insider Own2.27%Inst Own78.63%
Insider Trans3.20%Inst Trans-11.39%
Short Float1.86%EarningsFeb 13/b
Analyst Recom1.00Target Price19.00
Avg Volume135.26K52W Range2.56 - 11.67
Apr-09-24 08:00AM ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference (PR Newswire) -7.20%
Mar-07-24 08:13PM ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS (PR Newswire)
Feb-26-24 01:14PM 12 $10 Stocks That Will Triple (Insider Monkey)
Feb-14-24 04:35AM ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results (GuruFocus.com)
Feb-13-24 07:25AM ESSA Pharma: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:00AM ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023 (PR Newswire)
Feb-07-24 08:47PM ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares (GuruFocus.com)
Feb-06-24 08:00AM ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire) +5.29%
Jan-25-24 10:00AM ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium (PR Newswire) -22.64%
Dec-21-23 04:13PM These Stocks under $10 Are Poised To Explode (Insider Monkey)
XXII - 22nd Century Group Inc - Stock Price Chart
TickerXXII [NASD]
Company22nd Century Group Inc
CountryUSA
IndustryTobacco
Market Cap9.07MEPS (ttm)-119.99
P/E-EPS this Y82.97%
Forward P/E-EPS next Y23.39%
PEG-EPS past 5Y-49.91%
P/S0.13EPS next 5Y-
P/B-EPS Q/Q37.36%
Dividend-Sales Q/Q-61.69%
Insider Own1.24%Inst Own6.21%
Insider Trans288.02%Inst Trans-
Short Float3.47%EarningsMar 28/b
Analyst Recom2.00Target Price53.28
Avg Volume1.44M52W Range1.45 - 180.91
Apr-18-24 05:00PM 22nd Century Group Announces Resignation of Sullivan and Mish from the Board of Directors (Newsfile)
09:00AM 22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule (Newsfile)
Apr-15-24 09:00AM 22nd Century Group to Participate in the Planet MicroCap Showcase on May 1-2, 2024 (Newsfile)
Apr-11-24 04:45PM 22nd Century Group Expands CMO Business with New Pinnacle Brand Cigarillo Products (Newsfile)
Apr-08-24 09:25AM 22nd Century Announces Plan to Eliminate Its Senior Secured Debt (Newsfile) -40.17%
09:01AM Why Is 22nd Century (XXII) Stock Down 33% Today? (InvestorPlace)
Apr-05-24 02:52PM Why Is 22nd Century Group (XXII) Stock Up 100% Today? (InvestorPlace) +140.54%
Apr-04-24 05:48PM 22nd Century Group (XXII) Signs Large New CMO Customer (Newsfile) -16.38%
Apr-01-24 02:59PM 22nd Century Group, Inc. (NASDAQ:XXII) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-28-24 12:53PM XXII Stock Earnings: 22nd Century Group Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -8.75%
1⋯10⋯151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.